PUBLISHER: IMARC | PRODUCT CODE: 1291493
PUBLISHER: IMARC | PRODUCT CODE: 1291493
Epinephrine Autoinjector Market by Dosage, Application, End User, and Region 2023-2028
Market Overview:
The global epinephrine autoinjector market size reached US$ 2.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.40% during 2023-2028. The increasing number of individuals with allergies, rising need for self-administrating medicines, and the launch of smart epinephrine autoinjector represent some of the key factors driving the market.
Epinephrine autoinjector is a medical device used to administer single dose epinephrine easily for treating severe allergic reactions caused by stings, bug bites, or drugs. It is designed to deliver the medication into the thigh muscle of an individual and works by constricting blood vessels and dilating the airways to minimize the symptoms of an allergic reaction. It is small and easy to carry and can be administered by individuals or healthcare professionals. At present, leading manufacturers are introducing epinephrine autoinjector with multiple doses of medications and adjustable dosages that enable the user to adjust the dose according to the severity of the allergic reaction and improve the effectiveness of the treatment. They are also incorporating audio and visual instructions to make it easier for individuals to use them in an emergency.
Epinephrine Autoinjector Market Trends:
The increasing number of individuals with allergies and allergic reactions and the rising need for self-administrating medicines represent one of the major factors driving the demand for epinephrine autoinjectors around the world. Moreover, the surging prevalence of arthritis, asthma, cancer, and chronic obstructive pulmonary disease (COPD) and the growing aging population, which is more prone to develop allergic reactions, is influencing the market positively. In addition, the increasing incidence of food allergies among the masses is bolstering the growth of the market. Apart from this, governing agencies of numerous countries are undertaking initiatives to promote the use of epinephrine autoinjectors in schools and other public spaces. This, coupled with the rising awareness about epinephrine autoinjectors, is contributing to the market growth. Furthermore, key players are introducing smart epinephrine autoinjectors that are integrated with advanced technologies, including Bluetooth connectivity, sensors, and machine learning, to make them more convenient, user friendly, and effective. Leading players are also launching mobile applications that can be connected to smartphones or other devices, allowing remote monitoring, tracking of usage and expiration dates, and ensuring the patient does not exceed the recommended dosage. These advancements can also help predict the likelihood of an allergic reaction and provide personalized recommendations for treatment. This, along with the incorporation of an automated external defibrillator (AED) in epinephrine autoinjectors to offer a comprehensive emergency response system, is creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global epinephrine autoinjector market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on dosage, application, and end user.
Dosage Insights:
- 0.15mg Epinephrine Autoinjector
- 0.3mg Epinephrine Autoinjector
- 0.5mg Epinephrine Autoinjector
The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the dosage. This includes 0.15mg epinephrine autoinjector, 0.3mg epinephrine autoinjector, and 0.5mg epinephrine autoinjector. According to the report, 0.3mg epinephrine autoinjector represented the largest segment.
Application Insights:
- Under 6 Years
- 6 to 12 Years
- Over 12 Years
A detailed breakup and analysis of the epinephrine autoinjector market based on the application has also been provided in the report. This includes under 6 years, 6 to 12 years, and over 12 years. According to the report, 6 to 12 years represented the largest segment.
End User Insights:
- Hospitals
- Clinics
- Others
The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the end user. This includes hospitals, clinics, and others. According to the report, hospitals represented the largest segment.
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for epinephrine autoinjectors. Some of the factors driving the North America epinephrine autoinjector market included the rising prevalence of allergies, increasing awareness about anaphylaxis, and the availability of cost-effective generic versions of autoinjectors.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global epinephrine autoinjector market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Adamis Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc., Antares Pharma Inc, Bausch Health, Kaleo Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global epinephrine autoinjector market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global epinephrine autoinjector market?
- What is the impact of each driver, restraint, and opportunity on the global epinephrine autoinjector market?
- What are the key regional markets?
- Which countries represent the most attractive epinephrine autoinjector markets?
- What is the breakup of the market based on the dosage?
- Which is the most attractive dosage in the epinephrine autoinjector market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the epinephrine autoinjector market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the epinephrine autoinjector market?
- What is the competitive structure of the global epinephrine autoinjector market?
- Who are the key players/companies in the global epinephrine autoinjector market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Epinephrine Autoinjector Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Dosage
- 6.1 0.15mg Epinephrine Autoinjector
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 0.3mg Epinephrine Autoinjector
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 0.5mg Epinephrine Autoinjector
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Application
- 7.1 Under 6 Years
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 6 to 12 Years
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Over 12 Years
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Adamis Pharmaceuticals Corporation
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.2 Amneal Pharmaceuticals Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.3 Antares Pharma Inc
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 SWOT Analysis
- 14.3.4 Bausch Health
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Kaleo Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Teva Pharmaceutical Industries Ltd.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Viatris Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.1 Adamis Pharmaceuticals Corporation
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
- Figure 1: Global: Epinephrine Autoinjector Market: Major Drivers and Challenges
- Figure 2: Global: Epinephrine Autoinjector Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Epinephrine Autoinjector Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Epinephrine Autoinjector Market: Breakup by Dosage (in %), 2022
- Figure 5: Global: Epinephrine Autoinjector Market: Breakup by Application (in %), 2022
- Figure 6: Global: Epinephrine Autoinjector Market: Breakup by End User (in %), 2022
- Figure 7: Global: Epinephrine Autoinjector Market: Breakup by Region (in %), 2022
- Figure 8: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Epinephrine Autoinjector (Under 6 Years) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Epinephrine Autoinjector (Under 6 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Epinephrine Autoinjector (6 to 12 Years) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Epinephrine Autoinjector (6 to 12 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Epinephrine Autoinjector (Over 12 Years) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Epinephrine Autoinjector (Over 12 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Epinephrine Autoinjector (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Epinephrine Autoinjector (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Epinephrine Autoinjector (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Epinephrine Autoinjector (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Epinephrine Autoinjector (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Epinephrine Autoinjector (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: North America: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: North America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: United States: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: United States: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: Canada: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: Canada: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: Asia-Pacific: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: Asia-Pacific: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: China: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: China: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: Japan: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: Japan: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: India: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: India: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: South Korea: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: South Korea: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: Australia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: Australia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: Indonesia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: Indonesia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Europe: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Europe: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Germany: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Germany: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: France: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: France: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: United Kingdom: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: United Kingdom: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: Italy: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: Italy: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: Spain: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: Spain: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: Russia: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: Russia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Latin America: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Latin America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Brazil: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Brazil: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Mexico: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Mexico: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Others: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Middle East and Africa: Epinephrine Autoinjector Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Middle East and Africa: Epinephrine Autoinjector Market: Breakup by Country (in %), 2022
- Figure 74: Middle East and Africa: Epinephrine Autoinjector Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Global: Epinephrine Autoinjector Industry: Drivers, Restraints, and Opportunities
- Figure 76: Global: Epinephrine Autoinjector Industry: Value Chain Analysis
- Figure 77: Global: Epinephrine Autoinjector Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Epinephrine Autoinjector Market: Key Industry Highlights, 2022 & 2028
- Table 2: Global: Epinephrine Autoinjector Market Forecast: Breakup by Dosage (in Million US$), 2023-2028
- Table 3: Global: Epinephrine Autoinjector Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 4: Global: Epinephrine Autoinjector Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 5: Global: Epinephrine Autoinjector Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Epinephrine Autoinjector Market: Competitive Structure
- Table 7: Global: Epinephrine Autoinjector Market: Key Players
